Michael F. Gerhards

Erasmus MC, OLVG

Papers

10

Total Citations

272

H-Index

6

About

Michael F. Gerhards is a leading surgical researcher whose work centers on advancing minimally invasive techniques in hepatopancreatobiliary and colorectal surgery, with a particular focus on robotic and laparoscopic approaches. He has made major contributions through landmark randomized controlled trials, including the LEOPARD and LEOPARD-2 studies, which rigorously compared minimally invasive versus open pancreaticoduodenectomy and distal pancreatectomy. These trials, cited over 150 times collectively, have provided critical evidence on postoperative recovery, cost-effectiveness, and quality of life. Gerhards has also pioneered the use of indocyanine green (ICG)-fluorescence imaging for real-time margin assessment during liver metastasis resection, a technique with 49 citations that promises to reduce tumor-positive margins. His nationwide analyses of robotic liver surgery in the Netherlands, with over 50 citations, have shaped implementation strategies and outcome benchmarks. Notably, his work on outpatient robotic hepatectomy challenges traditional recovery paradigms. Gerhards’ research is instrumental in defining the safety, efficacy, and future direction of minimally invasive surgery, making him a key figure in surgical innovation.

Research Focus

Key Achievements

6
H-Index
10
Papers
272
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive versus open pancreatoduodenectomy (LEOPARD-2): study protocol for a randomized controlled trial
95 citations · 2018
📈 Most Prolific Year: 2024 (6 Papers)
🤝 Key Collaborators: 149
🏛 Institutions: Erasmus MC, OLVG

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago